Dipyridamole ๐
โ ๏ธ Dipyridamole commonly causes headache (due to vasodilation),
so start at a low dose if needed. Modified-release (MR) 200 mg BD is preferred in UK practice.
Headache usually improves after the first few days.
๐ About
- Antiplatelet and coronary vasodilator agent.
- Often used with aspirin in secondary prevention of TIA and ischaemic stroke, if clopidogrel is unsuitable.
- Also used IV as a vasodilator in myocardial perfusion scanning.
โ๏ธ Mode of Action
- Inhibits platelet phosphodiesterase โ โ intracellular cAMP โ โ platelet aggregation.
- Blocks uptake of adenosine into erythrocytes and endothelium โ โ extracellular adenosine โ vasodilation and further antiplatelet effect.
- Coronary vasodilation can sometimes worsen angina (rare โcoronary stealโ phenomenon).
๐ฉบ Indications
- Secondary prevention of TIA/ischaemic stroke: usually with aspirin; MR dipyridamole preferred (NICE CG68).
- Additional antiplatelet therapy: e.g., in selected patients post-CABG.
- Diagnostic use: IV dipyridamole in myocardial perfusion scans.
๐ Dosing โ Dipyridamole (BNF; verify with local policy)
| Formulation |
Details |
| ๐ Standard release |
โข 100 mg PO QDS
|
| ๐ Modified release |
โข 200 mg PO BD
โข โ
Preferred in UK practice
|
โ ๏ธ Cautions
- Aortic stenosis.
- Unstable angina, ischaemic heart disease (risk of coronary steal).
- Hypotension.
๐ซ Contraindications
- Severe coronary artery disease / unstable angina.
- Severe hypotension.
โ Side Effects
- Headache (very common, due to vasodilation).
- Flushing, dizziness, nausea, diarrhoea.
- Hypotension, rash.
- Worsening angina (rare).
- Bleeding risk (when used with other antiplatelets).
๐ References